IL128870A0 - Pharmaceutical compositions for treating fungal infections - Google Patents

Pharmaceutical compositions for treating fungal infections

Info

Publication number
IL128870A0
IL128870A0 IL12887097A IL12887097A IL128870A0 IL 128870 A0 IL128870 A0 IL 128870A0 IL 12887097 A IL12887097 A IL 12887097A IL 12887097 A IL12887097 A IL 12887097A IL 128870 A0 IL128870 A0 IL 128870A0
Authority
IL
Israel
Prior art keywords
inhibitors
antifungal
combination
xmp
polyenes
Prior art date
Application number
IL12887097A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620739.4A external-priority patent/GB9620739D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL128870A0 publication Critical patent/IL128870A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12887097A 1996-09-12 1997-09-09 Pharmaceutical compositions for treating fungal infections IL128870A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2632796P 1996-09-12 1996-09-12
GBGB9620739.4A GB9620739D0 (en) 1996-10-04 1996-10-04 Antifungal combination therapy
PCT/US1997/015987 WO1998010782A1 (en) 1996-09-12 1997-09-09 Antifungal combination therapy

Publications (1)

Publication Number Publication Date
IL128870A0 true IL128870A0 (en) 2000-06-01

Family

ID=26310166

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12887097A IL128870A0 (en) 1996-09-12 1997-09-09 Pharmaceutical compositions for treating fungal infections

Country Status (21)

Country Link
EP (1) EP0925070B1 (et)
JP (1) JP3288051B2 (et)
KR (1) KR100380871B1 (et)
CN (1) CN1235554A (et)
AT (1) ATE248625T1 (et)
AU (1) AU721334B2 (et)
CA (1) CA2265824C (et)
CY (1) CY2481B1 (et)
CZ (1) CZ88499A3 (et)
DE (1) DE69724626T2 (et)
DK (1) DK0925070T3 (et)
EA (1) EA002469B1 (et)
EE (1) EE03748B1 (et)
ES (1) ES2203819T3 (et)
IL (1) IL128870A0 (et)
NO (1) NO991207L (et)
NZ (1) NZ334446A (et)
PL (1) PL333282A1 (et)
PT (1) PT925070E (et)
SK (1) SK29999A3 (et)
WO (1) WO1998010782A1 (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9600117A (et) * 1994-11-08 1997-04-15 Glaxo Wellcome S.A Antifungaalsed sordariini derivaadid
US6069126A (en) * 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
KR100680464B1 (ko) * 2000-06-28 2007-02-08 주식회사 하이닉스반도체 반도체 소자의 캐패시터 제조 방법
JPWO2002098463A1 (ja) * 2001-06-05 2004-09-16 財団法人新産業創造研究機構 抗真菌組成物
CN101151032B (zh) 2005-04-07 2011-06-22 富山化学工业株式会社 药物组合物和联合使用抗真菌剂的方法
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
RU2429843C2 (ru) 2006-10-06 2011-09-27 Тояма Кемикал Ко., Лтд. Фармацевтическая композиция, включающая производное фениламидина, и способ применения фармацевтической композиции в комбинации с противогрибковым средством
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
US20110076240A1 (en) * 2008-04-18 2011-03-31 Day Donal F Antifungal and Anti-Cariogenic Cellobio-Oligosaccharides Produced by Dextransucrase
CN102274215B (zh) * 2010-06-10 2013-04-10 吉林大学 一种具有与氟康唑协同抗真菌作用的增效剂
CN102274217B (zh) * 2010-06-10 2013-04-10 吉林大学 三氯生作为抗真菌药物氟康唑增效剂的新用途
CN102274216B (zh) * 2010-06-10 2013-04-10 吉林大学 一种提高氟康唑抗真菌作用的增效剂
JPWO2012060448A1 (ja) 2010-11-05 2014-05-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
RU2013157207A (ru) * 2011-05-24 2015-06-27 БАЙЕР КРОПСАЙЕНС ЭлПи Синергетические комбинации полиеновых фунгицидов и нерибосомальных пептидов и связанные с ними способы применения
CN102319326A (zh) * 2011-07-23 2012-01-18 李玮 一种治疗脚癣的浸药卫生纸
CN115721633B (zh) * 2022-03-25 2024-05-03 山东大学 羟基茜草素在作为t3ss小分子抑制剂中的应用
CN116473985A (zh) * 2023-03-29 2023-07-25 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
AU721334B2 (en) 2000-06-29
DE69724626T2 (de) 2004-07-29
PT925070E (pt) 2003-12-31
EE03748B1 (et) 2002-06-17
EP0925070A1 (en) 1999-06-30
NZ334446A (en) 2000-11-24
EE9900088A (et) 1999-10-15
CA2265824A1 (en) 1998-03-19
JP3288051B2 (ja) 2002-06-04
EP0925070B1 (en) 2003-09-03
SK29999A3 (en) 2000-02-14
EA002469B1 (ru) 2002-06-27
ATE248625T1 (de) 2003-09-15
KR20000036054A (ko) 2000-06-26
CA2265824C (en) 2004-11-09
AU4339297A (en) 1998-04-02
CZ88499A3 (cs) 1999-10-13
PL333282A1 (en) 1999-11-22
DK0925070T3 (da) 2003-12-01
CY2481B1 (en) 2005-06-03
CN1235554A (zh) 1999-11-17
JP2000503675A (ja) 2000-03-28
KR100380871B1 (ko) 2003-04-18
ES2203819T3 (es) 2004-04-16
EA199900283A1 (ru) 1999-08-26
WO1998010782A1 (en) 1998-03-19
NO991207L (no) 1999-05-11
NO991207D0 (no) 1999-03-11
DE69724626D1 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
IL128870A0 (en) Pharmaceutical compositions for treating fungal infections
Galgiani Fluconazole, a new antifungal agent
Rousey et al. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
WO2000072865A3 (en) Antifungal combination use
BR0207024A (pt) Medicamento com ação inicial rápida para o tratamento de disfunção sexual
Sugar et al. Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis
Polak Combination therapy for systemic mycosis
Clark et al. The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C
BRPI0418623A (pt) composição farmacêutica, e, embalagem
US6069126A (en) Antifungal combination therapy
Meletiadis et al. Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans
WO2001066551A8 (en) Azole compounds as therapeutic agents for fungal infections
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
Shinohara et al. Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS
MXPA99002401A (en) Antifungal combination therapy
Calandra et al. Response to van Saene et al.'s comment on" Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"
IT1297538B1 (it) Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
CN1669554A (zh) 脂质体活力康唑制剂
MXPA02007641A (es) Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
during Therapy Multiechinocandin-and
HUP0000127A2 (hu) Több hatóanyagot tartalmazó antimikotikus kompozíció